New approach to ovarian cancer treatment uses RNA-based nanodrugs
| Date | 27th, Apr 2023 |
|---|---|
| Source | Technology Org - Scientific News Websites |
DESCRIPTION
In a study conducted at Tel Aviv University (TAU), the protein CKAP5 (cytoskeleton-associated protein) was used for the first time as a therapeutic target for RNA-based nanodrugs.